ArticleWorld journal of oncology2026

Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced/Metastatic Breast Cancer.

Αntria Savvidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.